Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prospective, double-blind, randomized, placebo-controlled crossover study of intravenous immunoglobulins in complex regional pain syndrome type I
2007-007794-23Phase 3Terminated
- Sponsor
- Justus Liebig University Giessen
- Start
- Jan 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of immune globulin in Complex Regional Pain Syndrome Type 1 (CRPS-1) (2 arms), sponsored by Justus Liebig University Giessen. Primary endpoint: Impairment Level SumScore (ISS) reduction >50%. Started Jan 2009; status: terminated.
02
Drugs
immune globulin
03
Conditions
Complex Regional Pain Syndrome Type 1 (CRPS-1)
Beyond the preview
Go deeper on 2007-007794-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-007794-23.